Finance

Beta
Lists
QNCX:NASDAQ
Quince Therapeutics Inc
$1.01
-8.18%
(-0.090) 1D
$1.06
+4.95% (+0.050)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNCX...
Open
$1.08
High
$1.09
Low
$1.01
Mkt. cap
16.46M
Avg. vol.
1.77M
Volume
797.85K
52-wk high
$45.50
52-wk low
$0.80
EPS
-$9.11
Beta
1.40
Shares outstanding
16.30M
No. of employees
38
Open
$1.08
High
$1.09
Low
$1.01
Mkt. cap
16.46M
Avg. vol.
1.77M
Volume
797.85K
52-wk high
$45.50
52-wk low
$0.80
EPS
-$9.11
Beta
1.40
Shares outstanding
16.30M
No. of employees
38
News stories
From sources across the web
About Quince Therapeutics Inc
CEO-
Employees38
Founded2012
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitequincetx.com
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$2.88 / -$2.60
+210.77%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.55M
8.08M
12.60M
6.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.34M
3.28M
3.64M
4.27M
Operating expense
9.90M
11.36M
16.24M
11.11M
Total operating expenses
9.90M
11.36M
16.24M
11.11M
Operating income
-9.90M
-11.36M
-16.24M
-11.11M
Other non operating income
-4.49M
233.00K
-17.12M
32.84M
EBT including unusual items
-15.98M
-13.49M
-36.31M
30.57M
EBT excluding unusual items
-14.95M
-10.87M
-32.65M
21.88M
Income tax expense
67.00K
-46.00K
3.15M
-5.34M
Effective tax rate
-0.42%
0.34%
-8.66%
-17.46%
Other operating expenses
-
-
-
-
Net income
-16.05M
-13.44M
-39.46M
35.91M
Net profit margin
-
-
-
-
Earnings per share
-3.25
-2.50
-7.60
2.88
Interest and investment income
311.00K
300.00K
227.00K
160.00K
Interest expense
-872.00K
-42.00K
-
-
Net interest expenses
-561.00K
258.00K
227.00K
160.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.86M
-11.33M
-16.20M
-11.08M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer